Prof. Dr. med. Carola Berking



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma (2022) Heppt M, Wessely A, Hornig E, Kammerbauer C, Graf SA, Besch R, French LE, et al. Journal article Drei Generationen Leiden: Cryopyrin-assoziiertes periodisches Syndrom mit familiärer NLRP3-Mutation (2022) Wagner N, Manger B, Kittler J, Rech J, Sticherling M, Berking C, Kirchberger M Journal article Single-Molecule RNA Sequencing Reveals IFN gamma-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines (2021) Sauerer T, Lischer C, Weich A, Berking C, Vera J, Dörrie J Journal article Increasing Participation Rates in Germany's Skin Cancer Screening Program (HELIOS): Protocol for a Mixed Methods Study (2021) Steeb T, Heppt M, Erdmann M, Wessely A, Klug SJ, Berking C Journal article Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial (2021) Voskens C, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, et al. Journal article BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation (2021) Hoyer S, Eberlein V, Schuler G, Berking C, Heinzerling L, Schaft N, Dörrie J Journal article, Original article c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis (2021) Steeb T, Wessely A, Petzold A, Kohl C, Erdmann M, Berking C, Heppt M Journal article, Review article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article DIVERSITY OF CD4(+) BLOOD T-CELL CLONALITY PREDICTS LONGER SURVIVAL WITH CTLA4 OR PD-1 CHECKPOINT INHIBITION IN ADVANCED MELANOMA (2021) Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt M, Berking C, Prinz JC Conference contribution A disease network-based deep learning approach for characterizing melanoma (2021) Lai X, Zhou J, Wessely A, Heppt M, Maier A, Berking C, Vera J, Zhang L Journal article, Original article